Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 35 for “"Deferiprone"”.

  1. Investigating the efficacy of Deferiprone and Gallium-protoporphyrin Chitogel in chronic wound infection

    … This thesis investigated the efficacy of Deferiprone (Def) and Gallium-protoporphyrin (GaPP) Chitogel, a medicated gel, for its antimicrobial effects against Staphylococcus aureus and Pseudomonas aeruginosa wound infections. By disrupting iron metabolism Def-GaPP Chitogel was able to …

    adelaide Repository record for Investigating the efficacy of Deferiprone and Gallium-protoporphyrin Chitogel in chronic wound infection (opens in a new tab)

  2. Exploring the synthesis and biological properties of Tobramycin-Deferiprone hybrids against Pseudomonas aeruginosa

    … with the target-site. Iron-chelator like deferiprone has been shown to be useful in addressing this non-selectivity by facilitating the binding of tetracycline to the target. Therefore, we hypothesize that we can utilize both properties in a hybrid molecule, i.e., membrane permeabilization …

    manitoba Repository record for Exploring the synthesis and biological properties of Tobramycin-Deferiprone hybrids against Pseudomonas aeruginosa (opens in a new tab)

  3. Investigation of The Efficacy of Some Hydroxypyridinone Iron Chelators

    … body iron homeostasis has been disrupted. CP20/deferiprone, which belongs to the 3-Hydroxypyridin-4-one (3-HPO) family, has been used as a clinically useful iron chelator by virtue of its oral activity and good iron mobilisation potency. However, it has been associated with some side effects due …

    kings Repository record for Investigation of The Efficacy of Some Hydroxypyridinone Iron Chelators (opens in a new tab) Download PDF for Investigation of The Efficacy of Some Hydroxypyridinone Iron Chelators (opens in a new tab)

  4. Disease modifying therapy for multiple system atrophy – Parkinsonian Type

    … with brain iron accumulation are iron chelators (Deferiprone) and tyrosine kinase inhibitors (Nilotinib.) METHODS: The proposed study is a multicenter, double blind, randomized control study of Nilotinib and Deferiprone for the treatment of MSA-P. There will be two treatment arms; Nilotinib and a …

    bu Repository record for Disease modifying therapy for multiple system atrophy – Parkinsonian Type (opens in a new tab)

  5. Zirconium-89 Complexes for Cell Tracking with Positron Emission Tomography

    … in hydrochloric or oxalic acid solution. A deferiprone complex was prepared from deferiprone and zirconium tetrachloride, but was found to lack lipophilic properties and it was not possible to prepare the deferiprone complex under radiopharmaceutical conditions. Analytical techniques such as …

    kent Download PDF for Zirconium-89 Complexes for Cell Tracking with Positron Emission Tomography (opens in a new tab)

  6. Novel Topical Anti-biofilm Agents in the Treatment of Recalcitrant Chronic Rhinosinusitis

    … gel by incorporating novel antimicrobial agents Deferiprone and Gallium Protoporphyrin (DG) into Chitogel. DG has a synergistic anti-biofilm effect against S. aureus and Methicillin Resistant S. aureus (MRSA) biofilms by targeting the iron metabolism pathway that is crucial for bacterial growth …

    adelaide Repository record for Novel Topical Anti-biofilm Agents in the Treatment of Recalcitrant Chronic Rhinosinusitis (opens in a new tab)

  7. Αποσιδήρωση παιδιών και εφήβων με ομόζυγη β-μεσογειακή αναιμία με νέο θεραπευτικό σχήμα: έλεγχος επίδρασης στο νευρικό και ανοσιακό σύστημα

    … application of a chelator per os. Since 2001, deferiprone constitutes an alternative solution for patients with thalassaemia, hemosiderosis and severe toxicity, during therapy with desferrioxamine. Deferiprone is being applicated as a monotherapy or combinated with desferrioxamine. The aim of …

    greece Repository record for Αποσιδήρωση παιδιών και εφήβων με ομόζυγη β-μεσογειακή αναιμία με νέο θεραπευτικό σχήμα: έλεγχος επίδρασης στο νευρικό και ανοσιακό σύστημα (opens in a new tab)

  8. Efficacia e sicurezza della terapia ferrochelante combinata in pazienti con talassemia major e grave sovraccarico di ferro intracardiaco

    … sicurezza della terapia ferrochelante combinata (deferiprone + desferrioxamina) in una coorte di pazienti con grave siderosi del miocardio (T2*cardiaco<10 ms). Vista la differente adesione al trattamento emersa nel corso dell’osservazione, si è tuttavia reso necessario suddividere i pazienti di …

    cagliari Repository record for Efficacia e sicurezza della terapia ferrochelante combinata in pazienti con talassemia major e grave sovraccarico di ferro intracardiaco (opens in a new tab)

  9. Διερεύνηση του ρόλου του οξειδωτικού στρες και της ομοιοστασίας του σιδήρου σε παθολογικές καταστάσεις

    … mobilize the “entrapped” iron. It was shown that deferiprone and deferasirox, contrary to desferrioxamine and caffeic acid, had the capacity to chelate intracellular iron and to protect the cellular DNA against H2O2-induced damage. Following, deferiprone, deferasirox and caffeic acid had the …

    greece Repository record for Διερεύνηση του ρόλου του οξειδωτικού στρες και της ομοιοστασίας του σιδήρου σε παθολογικές καταστάσεις (opens in a new tab)

  10. Topical Therapies for the Management of Recalcitrant Chronic Rhinosinusitis

    … a hydrogel composed of chitosan and dextran, and deferiprone, an iron chelating drug are reviewed for their potential to improve surgical outcomes. A review of sinonasal delivery devices for topical delivery of medication is presented with particular reference to intranasal nebulisers. The second …

    adelaide Repository record for Topical Therapies for the Management of Recalcitrant Chronic Rhinosinusitis (opens in a new tab)

  11. Prediction of Physicochemical Properties For Fe3+ Chelating Agents

    … for Fe3+ along with good oral activity. Deferiprone, a typical HPO, has emerged as a prominent therapeutic, able to remove accumulated excess iron from the heart and mitochondria. However, because Deferiprone has some drawbacks of relatively high metabolic instability and a side effect of …

    kings Repository record for Prediction of Physicochemical Properties For Fe3+ Chelating Agents (opens in a new tab) Download PDF for Prediction of Physicochemical Properties For Fe3+ Chelating Agents (opens in a new tab)

  12. Διερεύνηση του ρόλου βιοδραστικών ενώσεων της διατροφής σε μοριακούς μηχανισμούς που έχουν σχέση με το οξειδωτικό στρες και την υγεία

    … pharmaceuticals, desferrioxamine and deferiprone, which have different lipophilicity and iron binding capacity, against reperfusion after a period of ischemia in liver. Initially, we observed that the protection of nuclear DNA in hepatic cells, in conditions of oxidative stress, was …

    greece Repository record for Διερεύνηση του ρόλου βιοδραστικών ενώσεων της διατροφής σε μοριακούς μηχανισμούς που έχουν σχέση με το οξειδωτικό στρες και την υγεία (opens in a new tab)

  13. Επίδραση δεφεριπρόνης σε in vivo μοντέλο αυτόλογης νεφρικής μεταμόσχευσης: πειραματική μελέτη σε χοίρους

    … agent desferoxamine. Another chelating agent deferiprone (L1)has been used in iron overload patients showing better results possibly due to its differentphysicochemical properties. Purpose: The purpose of this study was to assess any possible protective effect of L1 on a …

    greece Repository record for Επίδραση δεφεριπρόνης σε in vivo μοντέλο αυτόλογης νεφρικής μεταμόσχευσης: πειραματική μελέτη σε χοίρους (opens in a new tab)

  14. Modifying Post-Surgical Wound Healing

    … Dextran Aldehyde a sugar, with added noveldrugs Deferiprone and Gallium Protoporphyrin providing additional anti scaring and antibiotic properties which could potentially augment the healing properties of the gel. I have conducted 3 types of studies. There are 2 animal studies and a Phase 1 Human …

    adelaide Repository record for Modifying Post-Surgical Wound Healing (opens in a new tab)

  15. A novel role for SENP3 in iron-chelation induced mitophagy for the treatment of Parkinson’s disease

    … was to understand how the iron chelating drug, Deferiprone (DFP), mediates its effects in mitophagy through Parkin/PINK1 independent mechanisms. DFP is an iron chelating drug currently in clinical trials for the treatment of Parkinson’s disease and has been shown to induce mitophagy …

    whiterose Download file for A novel role for SENP3 in iron-chelation induced mitophagy for the treatment of Parkinson’s disease (opens in a new tab)

  16. Sugar Conjugates of 3-Hydroxy-4-pyridinones : Synthesis and Investigations into their Potential for Drug Delivery to the Brain.

    … the basis of the clinically used iron chelator deferiprone. Hydroxypyridinone iron chelators could be linked to the sugars via ether, amide and triazole linkers, but the deprotection of the resulting conjugates could only be achieved for some molecules, while others could not be successfully …

    kings Repository record for Sugar Conjugates of 3-Hydroxy-4-pyridinones : Synthesis and Investigations into their Potential for Drug Delivery to the Brain. (opens in a new tab) Download PDF for Sugar Conjugates of 3-Hydroxy-4-pyridinones : Synthesis and Investigations into their Potential for Drug Delivery to the Brain. (opens in a new tab)

  17. Ηλεκτροφυσιολογική μελέτη οφθαλμών σε ασθενείς με βήτα μεσογειακή αναιμία

    … (group B, n = 11) or deferoxamine with deferiprone (group C, n = 14) and fourteen age- and sex- matched healthy individuals were included in the study. All participants underwent ophthalmoscopy, full-field electroretinography (ERG), visual evoked potentials (VEP), multifocal …

    greece Repository record for Ηλεκτροφυσιολογική μελέτη οφθαλμών σε ασθενείς με βήτα μεσογειακή αναιμία (opens in a new tab)

  18. Presence and Role of Acanthamoeba in Wound Infections

    … is iron. The role of iron chelators, including deferiprone and selected novel compounds based on hydroxyl pyridine moiety, was studied. Findings revealed that all novel iron chelators have an antimicrobial activity against both bacteria. In addition, all novel iron chelators were able to kill …

    essex Download PDF for Presence and Role of Acanthamoeba in Wound Infections (opens in a new tab)

  19. Development of a cardiac-targeted macromolecular chelator for the treatment of iron overload

    … Fe³⁺ chelators such as deferoxamine (DFO), deferiprone (L1) and deferasirox (DFX) which suffer from short circulation time, low iron excretion efficiency, and adverse side effects. To date, no methods are available to remove iron from specific organs to prevent organ toxicity; consequently, …

    ubc Repository record for Development of a cardiac-targeted macromolecular chelator for the treatment of iron overload (opens in a new tab) Download PDF for Development of a cardiac-targeted macromolecular chelator for the treatment of iron overload (opens in a new tab)

Page 1 of 2